|
SLC35A3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01390004672675E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21339999995074E-07 |
| Normal-vs-Stage2 |
8.06419999999086E-07 |
| Normal-vs-Stage3 |
1.7807999519448E-09 |
| Normal-vs-Stage4 |
2.78200000036755E-07 |
| Stage1-vs-Stage2 |
6.321000E-01 |
| Stage1-vs-Stage3 |
3.512200E-01 |
| Stage1-vs-Stage4 |
3.863800E-01 |
| Stage2-vs-Stage3 |
8.878800E-01 |
| Stage2-vs-Stage4 |
7.341800E-01 |
| Stage3-vs-Stage4 |
7.884400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.08270000134902E-08 |
| Normal-vs-AfricanAmerican |
7.640100E-04 |
| Normal-vs-Asian |
7.68300001396938E-09 |
| Caucasian-vs-AfricanAmerican |
6.313800E-01 |
| Caucasian-vs-Asian |
1.559850E-01 |
| AfricanAmerican-vs-Asian |
1.543770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.43439737654694E-11 |
| Normal-vs-Female |
6.48950000403659E-08 |
| Male-vs-Female |
8.774300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04469999995249E-06 |
| Normal-vs-Age(41-60Yrs) |
3.69549946199754E-10 |
| Normal-vs-Age(61-80Yrs) |
1.30870000392136E-08 |
| Normal-vs-Age(81-100Yrs) |
1.126070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.924200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.513400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.654000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.836200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.898400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.871200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.508800E-01 |
| Classical-VS-Follicular |
8.816000E-01 |
| Classical-VS-Other |
1.560250E-01 |
| Classical-VS-Normal |
3.00110000184262E-08 |
| Tall-VS-Follicular |
6.328400E-01 |
| Tall-VS-Other |
1.079040E-01 |
| Tall-VS-Normal |
1.68353999999704E-05 |
| Follicular-VS-Other |
3.219500E-02 |
| Follicular-VS-Normal |
1.6122999999979E-05 |
| Other-VS-Normal |
2.180200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9047999955113E-08 |
| Normal-vs-N1 |
9.0570000388368E-09 |
| N0-vs-N1 |
2.389000E-01 |
|
|
